Literature DB >> 19533578

Estrogenic and neuroprotective properties of scutellarin from Erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer's disease.

Judy T T Zhu1, Roy C Y Choi, Jun Li, Heidi Q H Xie, Cathy W C Bi, Anna W H Cheung, Tina T X Dong, Zhi Y Jiang, Ji J Chen, Karl W K Tsim.   

Abstract

Besides the classical hormonal effect, estrogen possesses neuroprotective effects in the brain, which leads to the searching of novel treatments for neurodegenerative diseases such as Alzheimer's disease. Scutellarin is a major flavone derived from Herba Erigerontis, a Chinese medicine derived from Erigeron breviscapus, which has been shown here to possess both estrogenic and neuroprotective properties. Scutellarin showed the estrogenic effects by activating the estrogen responsive elements and phosphorylation of estrogen receptor alpha in cultured MCF-7 cells: the activation was in a dose-dependent manner. On the other hand, scutellarin inhibited the aggregation of beta-amyloid in vitro, and prevented the cell death mediated by beta-amyloid when applied to cultured neuronal PC12 cells. These results therefore suggested that Herba Erigerontis and its component scutellarin might have therapeutic effects against postmenopausal symptoms and Alzheimer's disease. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533578     DOI: 10.1055/s-0029-1185776

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  12 in total

1.  Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.

Authors:  Jian-feng Xing; Hai-sheng You; Ya-lin Dong; Jun Lu; Si-ying Chen; Hui-fang Zhu; Qian Dong; Mao-yi Wang; Wei-hua Dong
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

Review 2.  Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia.

Authors:  Yun Yuan; Ming Fang; Chun-Yun Wu; Eng-Ang Ling
Journal:  Neuromolecular Med       Date:  2016-04-21       Impact factor: 3.843

3.  Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.

Authors:  Li-li Guo; Zhi-zhong Guan; Yong-lin Wang
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

4.  Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach.

Authors:  Zi-Qi Meng; Jia-Rui Wu; Ying-Li Zhu; Wei Zhou; Chang-Geng Fu; Xin-Kui Liu; Shu-Yu Liu; Meng-Wei Ni; Si-Yu Guo
Journal:  Chin J Integr Med       Date:  2020-05-22       Impact factor: 1.978

Review 5.  Risks and benefits related to alimentary exposure to xenoestrogens.

Authors:  Ilaria Paterni; Carlotta Granchi; Filippo Minutolo
Journal:  Crit Rev Food Sci Nutr       Date:  2017-11-02       Impact factor: 11.176

6.  Closed gateways--can neuroprotectants shield the retina in glaucoma?

Authors:  Thirumurthy Velpandian
Journal:  Drugs R D       Date:  2010

7.  Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult.

Authors:  Hao Tang; Yuping Tang; Nian-Guang Li; Hang Lin; Weixia Li; Qianping Shi; Wei Zhang; Pengxuan Zhang; Zexi Dong; Minzhe Shen; Ting Gu; Jin-Ao Duan
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease.

Authors:  Roy C Y Choi; Judy T T Zhu; Amanda W Y Yung; Pinky S C Lee; Sherry L Xu; Ava J Y Guo; Kevin Y Zhu; Tina T X Dong; Karl W K Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-24       Impact factor: 2.629

9.  Song bu li decoction, a traditional uyghur medicine, protects cell death by regulation of oxidative stress and differentiation in cultured PC12 cells.

Authors:  Maitinuer Maiwulanjiang; Kevin Y Zhu; Jianping Chen; Abudureyimu Miernisha; Sherry L Xu; Crystal Y Q Du; Kitty K M Lau; Roy C Y Choi; Tina T X Dong; Haji A Aisa; Karl W K Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-28       Impact factor: 2.629

Review 10.  Application of Metabolomics in Alzheimer's Disease.

Authors:  Jordan Maximillian Wilkins; Eugenia Trushina
Journal:  Front Neurol       Date:  2018-01-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.